Dolutegravir/Abacavir/Lamivudine
Dolutegravir/Abacavir/Lamivudine was ranked 1721st of 1,792 medicines by items in April 2026, with 1 items.
Dispensed in April 2026
Rolling 12 months
Net ingredient cost · April 2026
Figure 1. Dolutegravir/Abacavir/Lamivudine: national items dispensed by month
Source: NHSBSA Prescription Cost Analysis, to April 2026
Embed this chart
At a glance
- Therapeutic class Antiviral drugs
- Presentations 1 shown
- Average cost / item £798.16
Top presentations, April 2026
The individual products dispensed under Dolutegravir/Abacavir/Lamivudine this month.
| Presentation | BNF code | Items | Net ingredient cost |
|---|---|---|---|
| Triumeq 50mg/600mg/300mg tablets | 0503010AZBBABAB | 1 | £798 |
Source: NHSBSA Prescription Cost Analysis · to April 2026 OGL v3.0
Where Dolutegravir/Abacavir/Lamivudine is dispensed
The regions and dispensing practices with the highest Dolutegravir/Abacavir/Lamivudine volumes.
Top regions
Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.
Compare Dolutegravir/Abacavir/Lamivudine with
Other medicines in the same BNF section, by prescribing volume.